MEDIFAST INC (MED): Price and Financial Metrics


-5.91 (-3.59%)

POWR Rating

Component Grades














  • Quality is the dimension where MED ranks best; there it ranks ahead of 91.97% of US stocks.
  • MED's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • MED ranks lowest in Stability; there it ranks in the 20th percentile.

MED Stock Summary

  • Medifast Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 95.63% of US listed stocks.
  • For MED, its debt to operating expenses ratio is greater than that reported by merely 8.6% of US equities we're observing.
  • With a year-over-year growth in debt of 191.58%, Medifast Inc's debt growth rate surpasses 94.21% of about US stocks.
  • Stocks that are quantitatively similar to MED, based on their financial statements, market capitalization, and price volatility, are LFVN, CNXN, SPWH, MAN, and CAL.
  • MED's SEC filings can be seen here. And to visit Medifast Inc's official web site, go to

MED Valuation Summary

  • MED's price/earnings ratio is 18.1; this is 6.7% lower than that of the median Consumer Cyclical stock.
  • Over the past 243 months, MED's price/earnings ratio has gone up 15.6.
  • MED's price/sales ratio has moved up 1.6 over the prior 243 months.

Below are key valuation metrics over time for MED.

Stock Date P/S P/B P/E EV/EBIT
MED 2021-08-27 2.1 14.0 18.1 12.9
MED 2021-08-26 2.1 13.4 17.3 12.4
MED 2021-08-25 2.0 13.4 17.3 12.4
MED 2021-08-24 2.1 13.5 17.4 12.5
MED 2021-08-23 2.1 13.7 17.7 12.7
MED 2021-08-20 2.1 13.4 17.4 12.4

MED Growth Metrics

    The 4 year price growth rate now stands at 151.15%.
  • Its year over year cash and equivalents growth rate is now at 127.23%.
  • Its 4 year cash and equivalents growth rate is now at 91.63%.
MED's revenue has moved up $957,804,000 over the prior 34 months.

The table below shows MED's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,526.087 94.545 164.031
2021-09-30 1,413.165 121.833 158.002
2021-06-30 1,271.24 147.147 150.473
2021-03-31 1,097.05 183.787 125.445
2020-12-31 934.842 145.196 102.859
2020-09-30 840.562 144.519 94.746

MED's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MED has a Quality Grade of A, ranking ahead of 99.43% of graded US stocks.
  • MED's asset turnover comes in at 4.143 -- ranking 1st of 59 Food Products stocks.
  • TWNK, TOFB, and KHC are the stocks whose asset turnover ratios are most correlated with MED.

The table below shows MED's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 4.143 0.744 19.148
2021-03-31 4.006 0.739 72.885
2020-12-31 3.851 0.746 8.172
2020-09-30 3.779 0.746 4.378
2020-06-30 3.670 0.745 2.384
2020-03-31 3.596 0.753 1.821

MED Price Target

For more insight on analysts targets of MED, see our MED price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $363.33 Average Broker Recommendation 1.33 (Strong Buy)

MED Stock Price Chart Interactive Chart >

Price chart for MED

MED Price/Volume Stats

Current price $158.52 52-week high $336.99
Prev. close $164.43 52-week low $156.09
Day low $156.09 Volume 185,900
Day high $162.97 Avg. volume 124,555
50-day MA $177.90 Dividend yield 3.99%
200-day MA $200.73 Market Cap 1.83B


Medifast Inc. is a manufacturer and provider of clinically weight-loss and weight-maintenance products and programs. The company was founded in 1980 and is based in Owings Mills, Maryland.

MED Latest News Stream

Event/Time News Detail
Loading, please wait...

MED Latest Social Stream

Loading social stream, please wait...

View Full MED Social Stream

Latest MED News From Around the Web

Below are the latest news stories about Medifast Inc that investors may wish to consider to help them evaluate MED as an investment opportunity.

Medifast's (MED) CEO Dan Chard on Q4 2021 Results - Earnings Call Transcript

Medifast, Inc. (MED) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Reed Anderson – Investor Relations-ICR, Inc. Dan Chard – Chairman and Chief Executive Officer Jim Maloney – Chief Financial Officer Conference Call Participants Steph Wissink – Jefferies Linda Bolton Weiser – D.A. Davidson Doug...

SA Transcripts on Seeking Alpha | February 24, 2022

Medifast hiring up to 300 people for new Harford County distribution center

The county — with its easy access to Interstate 95 — is a favorite among companies looking to distribute goods by highway.

Yahoo | February 24, 2022

Medifast (MED) Q4 Earnings Beat, Strength in OPTAVIA Key Driver

Medifast's (MED) fourth-quarter 2021 results reflect stellar earnings and revenues, courtesy of continued strength in OPTAVIA. Sales and earnings view for 2022 reflect year-over-year growth.

Yahoo | February 24, 2022

Medifast (MED) Surpasses Q4 Earnings and Revenue Estimates

Medifast (MED) delivered earnings and revenue surprises of 8.99% and 0.49%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Medifast, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results

Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2021.

Yahoo | February 23, 2022

Read More 'MED' Stories Here

MED Price Returns

1-mo -15.90%
3-mo -9.61%
6-mo -27.04%
1-year -48.57%
3-year 20.18%
5-year 325.60%
YTD -23.58%
2021 9.36%
2020 86.18%
2019 -9.73%
2018 82.11%
2017 72.33%

MED Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MED Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8667 seconds.